BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 29903537)

  • 1. Predictors of positive
    Prieto-Peña D; Martínez-Rodríguez I; Loricera J; Banzo I; Calderón-Goercke M; Calvo-Río V; González-Vela C; Corrales A; Castañeda S; Blanco R; Hernández JL; González-Gay MÁ
    Semin Arthritis Rheum; 2019 Feb; 48(4):720-727. PubMed ID: 29903537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of
    Slart RHJA; Nienhuis PH; Glaudemans AWJM; Brouwer E; Gheysens O; van der Geest KSM
    J Nucl Med; 2023 Apr; 64(4):515-521. PubMed ID: 37011940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FDG-PET/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC.
    Slart RHJA; ; ; ; ; ; ; ;
    Eur J Nucl Med Mol Imaging; 2018 Jul; 45(7):1250-1269. PubMed ID: 29637252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (18)F-FDG PET/CT for the detection of large vessel vasculitis in patients with polymyalgia rheumatica.
    Lavado-Pérez C; Martínez-Rodríguez I; Martínez-Amador N; Banzo I; Quirce R; Jiménez-Bonilla J; De Arcocha-Torres M; Bravo-Ferrer Z; Jiménez-Alonso M; López-Defilló JL; Blanco R; González-Gay MA; Carril JM
    Rev Esp Med Nucl Imagen Mol; 2015; 34(5):275-81. PubMed ID: 26159505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-B52 allele in giant cell arteritis may indicate diffuse large-vessel vasculitis formation: a retrospective study.
    Kushimoto K; Ayano M; Nishimura K; Nakano M; Kimoto Y; Mitoma H; Ono N; Arinobu Y; Akashi K; Horiuchi T; Niiro H
    Arthritis Res Ther; 2021 Sep; 23(1):238. PubMed ID: 34517892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The usefulness of 18F-FDG-PET/CT in detecting musculoskeletal and vascular involvement in patients with polymyalgia rheumatica receiving glucocorticoids.
    Serrano-Combarro A; Prieto-Peña D; Martínez-Rodríguez I; Martínez-Amador N; Loricera J; Blanco R
    Eur J Intern Med; 2024 Jun; 124():78-83. PubMed ID: 38302404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Various forms of (18)F-FDG PET and PET/CT findings in patients with polymyalgia rheumatica.
    Rehak Z; Vasina J; Nemec P; Fojtik Z; Koukalova R; Bortlicek Z; Rehakova D; Adam J; Vavrusova A; Adam Z
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Dec; 159(4):629-36. PubMed ID: 26006092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do statins decrease vascular inflammation in patients at risk for large-vessel vasculitis? A retrospective observational study with FDG-PET/CT in polymyalgia rheumatica, giant cell arteritis and fever of unknown origin.
    Iannuzzi F; Hysa E; Camellino D; Morbelli S; Bauckneht M; Sambuceti G; Cutolo M; Cimmino MA
    Clin Exp Rheumatol; 2023 Apr; 41(4):812-820. PubMed ID: 37073635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole-body fluorodeoxyglucose positron emission tomography/computed tomography in patients with active polymyalgia rheumatica: evidence for distinctive bursitis and large-vessel vasculitis.
    Yamashita H; Kubota K; Takahashi Y; Minaminoto R; Morooka M; Ito K; Kano T; Kaneko H; Takashima H; Mimoiri A
    Mod Rheumatol; 2012 Sep; 22(5):705-11. PubMed ID: 22205118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early large vessel systemic vasculitis in adults.
    González-Gay MA; Prieto-Peña D; Martínez-Rodríguez I; Calderon-Goercke M; Banzo I; Blanco R; Castañeda S
    Best Pract Res Clin Rheumatol; 2019 Aug; 33(4):101424. PubMed ID: 31810548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and FDG-PET/CT correlates in patients with polymyalgia rheumatica.
    Camellino D; Paparo F; Morbelli SD; Pesce G; Bauckneht M; Bagnasco M; Cutolo M; Sambuceti G; Cimmino MA
    Clin Exp Rheumatol; 2022 Jan; 40(1):78-85. PubMed ID: 33822711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymyalgia rheumatica and giant cell arteritis-three challenges-consequences of the vasculitis process, osteoporosis, and malignancy: A prospective cohort study protocol.
    Emamifar A; Hess S; Gerke O; Hermann AP; Laustrup H; Hansen PS; Thye-Rønn P; Marcussen N; Svendstrup F; Gildberg-Mortensen R; Bang JC; Farahani ZA; Chrysidis S; Toftegaard P; Andreasen RA; le Greves S; Andersen HR; Olsen RN; Hansen IMJ
    Medicine (Baltimore); 2017 Jun; 96(26):e7297. PubMed ID: 28658131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation between Polymyalgia Rheumatica (PMR) and Elderly-Onset Rheumatoid Arthritis Using 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography: Is Enthesitis a New Pathological Lesion in PMR?
    Wakura D; Kotani T; Takeuchi T; Komori T; Yoshida S; Makino S; Hanafusa T
    PLoS One; 2016; 11(7):e0158509. PubMed ID: 27384410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in polymyalgia rheumatica: an observational study.
    Casadepax-Soulet C; Benali K; Crestani B; Piekarski E; Mahida B; Ebstein E; Juge PA; Forien M; Dieudé P; Ottaviani S
    Clin Exp Rheumatol; 2023 Jul; 41(7):1456-1462. PubMed ID: 36533978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High frequency of capsular knee involvement in polymyalgia rheumatica/giant cell arteritis patients studied by positron emission tomography.
    Cimmino MA; Camellino D; Paparo F; Morbelli S; Massollo M; Cutolo M; Sambuceti G
    Rheumatology (Oxford); 2013 Oct; 52(10):1865-72. PubMed ID: 23850896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of 18F-fluorodeoxyglucose positron emission tomography-computed tomography in patients affected by polymyalgia rheumatica and persistent increase of acute phase reactants.
    Colaci M; Dichiara J; Aprile ML; Ippolito M; Schinocca C; Guggino G; Malatino L
    Front Med (Lausanne); 2022; 9():1042620. PubMed ID: 36465900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of
    Pean de Ponfilly-Sotier M; Besson FL; Gomez L; Ottaviani S; Dieudé P; Pavy S; Mariette X; Seror R; Nocturne G
    Joint Bone Spine; 2022 May; 89(3):105325. PubMed ID: 34915108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormalities at three musculoskeletal sites on whole-body positron emission tomography/computed tomography can diagnose polymyalgia rheumatica with high sensitivity and specificity.
    Owen CE; Poon AMT; Yang V; McMaster C; Lee ST; Liew DFL; Leung JL; Scott AM; Buchanan RRC
    Eur J Nucl Med Mol Imaging; 2020 Sep; 47(10):2461-2468. PubMed ID: 32090280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic value of [18F]FDG-PET/CT in polymyalgia rheumatica: a systematic review and meta-analysis.
    van der Geest KSM; Treglia G; Glaudemans AWJM; Brouwer E; Jamar F; Slart RHJA; Gheysens O
    Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1876-1889. PubMed ID: 33372248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New arguments for a vasculitic nature of polymyalgia rheumatica using positron emission tomography.
    Blockmans D; Maes A; Stroobants S; Nuyts J; Bormans G; Knockaert D; Bobbaers H; Mortelmans L
    Rheumatology (Oxford); 1999 May; 38(5):444-7. PubMed ID: 10371283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.